Facebook
Twitter
Telegram
Report an ErrorGenMark Diagnostics, Inc. Financial Statements 2011-2024 | GNMK
Annual Financial Statements GenMark Diagnostics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
933 M | 317 M | 361 M | 271 M | 523 M | 223 M | 533 M | 441 M | 279 M | 74.4 M |
Shares |
67.5 M | 57.6 M | 55.7 M | 51.2 M | 44.1 M | 42.2 M | 41.3 M | 35.3 M | 26.2 M | 16.6 M |
Net Income |
-18.6 M | -47.4 M | -50.5 M | -61.8 M | -50.6 M | -42.2 M | -38.3 M | -33.6 M | -22.1 M | -24 M |
Revenue |
172 M | 88 M | 70.8 M | 52.5 M | 49.3 M | 39.4 M | 30.6 M | 27.4 M | 20.5 M | 5.01 M |
EBITDA |
-3.98 M | -34.5 M | -40.7 M | -54.2 M | -45.1 M | -38.1 M | -36.4 M | -32.4 M | -20.7 M | -22.5 M |
Operating Expenses |
79 M | 70.4 M | 67.3 M | 79.5 M | 78.6 M | 65.6 M | 56.5 M | 46.4 M | 30.7 M | 22.7 M |
General and Administrative Expenses |
25.6 M | 19.2 M | 17.5 M | 16.2 M | 14.4 M | 13.8 M | 12.1 M | 11.5 M | 10.8 M | 8.96 M |
All numbers in USD currency